TY - JOUR
T1 - Comparison of Escherichia coli susceptibility to cephalothin, cefazolin, ceforanide, and cefamandole
AU - Greenberg, R. N.
AU - Bollinger, M.
PY - 1985
Y1 - 1985
N2 - Twenty-seven Escherichia coli test strains that were not susceptible to cephalothin were tested for susceptibility to cefazolin, cefamandole, and ceforanide. By zone-size criteria (≥ 18 mm), 67% of E. coli were susceptible to cefazolin and cefamandole, and 93% were susceptible to ceforanide. By microtiter assay (MIC ≤ 8 μg/ml), 88% were susceptible to cefazolin and cefamandole, and 94% were susceptible to ceforanide. The results support susceptibility testing of E. coli with specific first- or second-generation cephalosporins rather than with class agents.
AB - Twenty-seven Escherichia coli test strains that were not susceptible to cephalothin were tested for susceptibility to cefazolin, cefamandole, and ceforanide. By zone-size criteria (≥ 18 mm), 67% of E. coli were susceptible to cefazolin and cefamandole, and 93% were susceptible to ceforanide. By microtiter assay (MIC ≤ 8 μg/ml), 88% were susceptible to cefazolin and cefamandole, and 94% were susceptible to ceforanide. The results support susceptibility testing of E. coli with specific first- or second-generation cephalosporins rather than with class agents.
UR - http://www.scopus.com/inward/record.url?scp=0021951878&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021951878&partnerID=8YFLogxK
M3 - Article
C2 - 3886140
AN - SCOPUS:0021951878
SN - 0149-2918
VL - 7
SP - 151
EP - 153
JO - Clinical Therapeutics
JF - Clinical Therapeutics
IS - 2
ER -